The Latest Cardiac and Vascular News
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended September 30, 2021. Q2 financial summary and operational highlights: Revenue for the quarter totaled $248.1 million, an increase of 18% compared to $209.8 million during the same period of […]
JENKINTOWN, Pa., Oct. 28, 2021 /PRNewswire/ — Adler Institute for Advanced Imaging and KDK Scientific, the leading independent clinical and research imaging facility in the Greater Philadelphia region, are excited to announce the expansion of their existing Cardiac PET/CT imaging services, with the installation of a dedicated superconducting cyclotron for the manufacture and production […]
Company Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After Stroke AUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) announced today its plan to commence a randomized, placebo-controlled clinical study to test its new True Human™ antibody therapy […]
CINCINNATI, Oct. 28, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer (EVP, CFO and CBDO). “Terry gained broad financial and operational leadership experience at several high-profile and start-up companies, including in […]
WAYNE, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter financial summary Reported revenues of $700.3 million, up 11.5% year-over-year; up 10.3% on a constant currency basis GAAP diluted EPS from continuing operations of […]
IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced positive acute and long-term interim results from the first 500 pulmonary embolism (“PE”) patients […]
The permanent heart implant is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation LAGUNA HILLS, CA – Oct. 28, 2021 — The MemorialCare Heart & Vascular Institute at Saddleback Medical Center recently performed its 100th WATCHMAN™ Left Atrial Appendage Closure Device procedure, […]
TIANJIN, China, Oct. 27, 2021 /PRNewswire/ — SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where investigators demonstrated equivalence in safety and effectiveness between the […]
TAMPA, Fla., Oct. 27, 2021 /PRNewswire/ — Keystone Heart Ltd., a Venus Medtech Company, today announced a key milestone in Europe with the TriGUARD 3 Cerebral Embolic Protection (CEP) Device. The device was granted CE mark in March of 2020 and, since launch, utilized in fourteen countries with zero physician-reported strokes. The TriGUARD 3 CEP device is the only […]
Market availability of the cardiovascular disease prevention module co-developed with Bayer demonstrates One Drop’s continued expansion into new therapeutic areas NEW YORK, Oct. 27, 2021 /PRNewswire/ — One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced the release of a digital, AI-enabled cardiovascular disease […]
